Search research articles
Contact Us
Filters
Showing results (11-20 of 68) with videos related to
Page
of 7
Sort By:
Genetics & Epigenetics
|
June 7, 2011
UHRF1 Links the Histone code and DNA Methylation to ensure Faithful Epigenetic Memory Inheritance
Christian Bronner, Guy Fuhrmann, Frédéric L Chédin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 12, 2021
ICBP90 Regulates MIF Expression, Glucocorticoid Sensitivity, and Apoptosis at the MIF Immune Susceptibility Locus
Jie Yao, Lin Leng, Weiling Fu, et al.
Genes
|
April 30, 2021
Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
Omeima Abdullah, Ziad Omran, Salman Hosawi, et al.
Cancer Research
|
August 19, 2007
Epigenetic modulation of estrogen receptor-alpha by pRb family proteins: a novel mechanism in breast cancer
Marcella Macaluso, Micaela Montanari, Paul Bart Noto, et al.
Pharmacology & Therapeutics
|
July 31, 2007
The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?
Christian Bronner, Mayada Achour, Yoshimi Arima, et al.
Anticancer Research
|
August 5, 2006
Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity
Frank Un, Christina Qi, Megan Prosser, et al.
Molecules (Basel, Switzerland)
|
August 26, 2023
Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1
Waseem Ashraf, Tanveer Ahmad, Nicolas Reynoird, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 20, 2008
Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells
Murielle Zerr-Fouineau, Marie Jourdain, Caroline Boesch, et al.
Oncology Letters
|
December 30, 2017
Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy
Hani Choudhry, Mazin A Zamzami, Ziad Omran, et al.
Cellular Signalling
|
September 3, 2010
Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis
Abdurazzag Abusnina, Mahmoud Alhosin, Thérèse Keravis, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 68) with videos related to
Sort By:
Page
of 7
Genetics & Epigenetics
|
June 7, 2011
UHRF1 Links the Histone code and DNA Methylation to ensure Faithful Epigenetic Memory Inheritance
Christian Bronner, Guy Fuhrmann, Frédéric L Chédin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 12, 2021
ICBP90 Regulates MIF Expression, Glucocorticoid Sensitivity, and Apoptosis at the MIF Immune Susceptibility Locus
Jie Yao, Lin Leng, Weiling Fu, et al.
Genes
|
April 30, 2021
Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
Omeima Abdullah, Ziad Omran, Salman Hosawi, et al.
Cancer Research
|
August 19, 2007
Epigenetic modulation of estrogen receptor-alpha by pRb family proteins: a novel mechanism in breast cancer
Marcella Macaluso, Micaela Montanari, Paul Bart Noto, et al.
Pharmacology & Therapeutics
|
July 31, 2007
The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?
Christian Bronner, Mayada Achour, Yoshimi Arima, et al.
Anticancer Research
|
August 5, 2006
Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity
Frank Un, Christina Qi, Megan Prosser, et al.
Molecules (Basel, Switzerland)
|
August 26, 2023
Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1
Waseem Ashraf, Tanveer Ahmad, Nicolas Reynoird, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 20, 2008
Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells
Murielle Zerr-Fouineau, Marie Jourdain, Caroline Boesch, et al.
Oncology Letters
|
December 30, 2017
Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy
Hani Choudhry, Mazin A Zamzami, Ziad Omran, et al.
Cellular Signalling
|
September 3, 2010
Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis
Abdurazzag Abusnina, Mahmoud Alhosin, Thérèse Keravis, et al.
Page
of 7